Speakers

PIONEERING ACADEMICS

Frank McCormick

Professor & Leader NCI RAS Initiative

Frederick National Laboratory for Cancer Research

Channing Der

Sarah Graham Kenan Distinguished Professor

University of North Caroline at Chapel Hill

Piro Lito

Assistant Member

Memorial Sloan Kettering Center

Ryan Corcoran

Associate Professor of Medicine

Harvard Medical School

Aaron Hata

Assistant Professor of Medicine

Harvard Medical School

Scott Kopetz

Distinguished Professor

MD Anderson Cancer Centre

Martin McMahon

Presidential Chair of Cancer Biology

Huntsman Cancer Institute of University of Utah

Greg Beilhartz

Senior Research Associate

The Hospital for Sick Children

Christine Pratilias

Associate Professor of Oncology & Pediatrics

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Miriam Molina-Arcas

Senior Laboratory Research Scientist

Francis Crick Institute

Jack Arbiser

Thomas Lawley Professor of Dermatology

Emory University School of Medicine

Antti Poso

Professor of Drug Design

University of Eastern Finland & University Hospital Tübingen

Pan-Yu Chen

Scientist

Plexxikon

Benham Nabet

Katherine Loker Pinard Fellow

Dana-Farber Cancer Institute

Bruce Gelb

Gogel Family Chair & Director

Mindich Child Health & Development Institute

Udai Banerji

Professor & Deputy Director of The Drug Development Unit

The Institute of Cancer Research, London

Jonas Kapp

PhD Candidate

Department of Biochemistry, University of Zurich

Gary Piazza

Professor

University of South Alabama & Chief Scientist, ADT Pharmaceuticals

GLOBAL LEADERS FROM LARGE PHARMA & BIOTECH

Steve Kelsey

President R&D

Revolution Medicines

Peter Hammerman

Global Head of Translational Oncology

Novartis

Bryan Smith

Vice President of Biological Sciences

Deciphera Pharmaceuticals

Francis Burrows

Vice President of Translational Research

Kura Oncology

Jonathan Pachter

Chief Scientific Officer

Verastem Oncology

Erik Digman-Wiklund

Chief Business Officer

Targovax

Lusong Luo

Senior Vice President, External Innovation

Beigene

Steven Fruchtman

President & Chief Executive Officer

Onconova Therpaeutics

Mark Erlander

Chief Executive Officer

Cardiff Oncology

Silvia Coma

Associate Director Preclinical Research

Verastem Oncology

Jan Smith

Vice President Biology

Revolution Medicines

Sreesha Srinivasa

Senior Vice President

Oblique Therapeutics

Steven Nadler

Vice President of Research

Aro Biotherapeutics

Matt Meyer

Senior Director & Head of In Vivo Biology

Tauseef Butt

Chief Executive Officer

Progenra

Shiva Malek

Senior Director & Head of Discovery Oncology

Genentech

Pete DeMuth

Vice President of Research

Elicio Therapeutics

Grahame McKenzie

Chief Scientific Officer

PhoreMost

Beth Stronach

Board Member & Parent Advocate

RASopathies Network

Erica Jackson

Senior Director

AbbVie

Marie Evangelista

Senior Scientist & Project Team Lead, Discovery Oncology

Genentech

Yibing Shan

Senior Scientist

D.E Shaw Research

Nicholas Heimann

Chief Executive Officer

Nicholas Pharmaceuticals

Chiara Ambrogio

Assistant Professor

University of Turin

Ida Aronchik

Principal Scientist

Bristol Myers Squibb

INNOVATING SOLUTION PROVIDERS

Matt Robers

Senior Research Scientist, Integrated Biology, R&D

Promega

Kerstin Pohl

Manager of Medical Affairs

Biodesix